Cash to Monthly Cash Expenses Ratio Amicus Therapeutics, Inc., is a biopharmaceu

ID: 2546558 • Letter: C

Question

Cash to Monthly Cash Expenses Ratio Amicus Therapeutics, Inc., is a biopharmaceutical company that develops drugs for the treatment of various diseases, including Parkinson's disease. Amicus Therapeutics reported the following financial data (in thousands) for three recent years: For Years Ended December 31 Year 2 $24,074 (51,669) Year 3 Year 1 $43,640 (45,794) Cash and cash equivalents Net cash flows from operations a. Determine the monthly cash expenses for Year 3, Year 2, and Year 1 (in thousands). Round to one decimal place. Year 3: Year 2: Year 1: b. Determine the ratio of cash to monthly cash expenses for Year 3, Year 2, and Year 1 as of December 31. Round to one decimal place. Year 3: Year 2: Year 1: $69,485 (100,139) per month per month per month months months months

Explanation / Answer

Year 1

Year 2

Year 3

Cash & Cash Equivalents

69,485

24,074

43,640

Net Cash Flows from Operations

1,00,139

51,669

45,794

Total Expenses

30,654

27,595

2,154

Monthly Cash Expenses

2,554.5

2,299.6

179.5

Ratio of Cash to Monthly Cash Expenses

27.2

10.5

243.1